What is the Norris Medicines Ltd share price today?

The share price of BSE:NORRIS-X on 07 Sep 2026 (as of 11:01:44 IST) is ₹13.65.

What is the BSE:NORRIS-X 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the BSE:NORRIS-X 52 week high low range shows a high of ₹19.63 and a low of ₹12.00.

What is the Norris Medicines Ltd market cap?

As on 07 Sep 2026, Norris Medicines Ltd market cap is ₹13.65 Cr.

What is the shareholding pattern of Norris Medicines Ltd Stock?

The shareholding pattern of Norris Medicines Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 34.01% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0.06% Mutual Funds: 0.01% Retail & Others: 65.92% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Norris Medicines Ltd?

The Price-to-Earnings (PE) ratio of Norris Medicines Ltd is 0, and the Price-to-Book (PB) ratio is -1.12, as on 07 Sep 2026.

Norris Medicines Share Price

19.67+0.00 (+0.00%)

+18.21% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.00%

1 Week

+7.84%

1 Month

+26.90%

3 Month

+45.27%

6 Month

+54.27%

YTD

+23.32%

1 Year

+18.21%

5 Year

+103.41%

10 Year

Max

+227.83%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

18.70

17.85

13.50

12.25

12.00

High

19.67

19.71

About

Norris Medicines Ltd. is one of the leading Indian manufacturers of Injections and Medicinal formulations.

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

ZYDUSLIFE-ANSE

CIPLA-ANSE

LAURUSLABS-ANSE

MANKIND-ANSE

DRREDDY-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

NORRIS-XNSE

LTP

1W Low

1W High

Market cap (₹)

1853+17.5 (0.95%)

1835.50

1890.40

4,47,476Cr

9613+246 (2.63%)

9305.95

9739.85

2,54,764Cr

4935+130.75 (2.72%)

4864.80

5010

1,89,423Cr

1180+27 (2.34%)

1152

1191

1,16,658Cr

1404+32.55 (2.37%)

1364

1418.70

1,11,484Cr

2026.25+71 (3.63%)

1964.50

2054.55

1,09,943Cr

2475+157 (6.77%)

2302.30

2503.20

1,01,712Cr

1200.4+29.3 (2.50%)

1186.20

1221.60

1,01,005Cr

1720-15 (-0.86%)

1690

1739.60

99,253Cr

2098-46.7 (-2.18%)

2084.50

2129.85

96,031Cr

19.67+1.43 (7.84%)

17.85

19.71

20Cr

Norris Medicines Share Price

19.67+0.00 (+0.00%)

+18.21% past 1 Year

Financial overview

Compounded Sales Growth

10 years-11%

5 years-6%

3 years-15%

Last year3%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-4%

Stock Price CAGR

10 years-

5 years16%

3 years20%

1 year23%

Return on Equity

10 years-23%

5 years0%

3 years0%

Last year0%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-11%	-6%	-15%	3%
-	-	-	-4%
-	16%	20%	23%
-23%	0%	0%	0%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

ZYDUSLIFE-A

CIPLA-A

LAURUSLABS-A

MANKIND-A

DRREDDY-A

AUROPHARMA-A

LUPIN-A

NORRIS-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,853	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,613	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,935	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,404	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.25	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,475	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,720	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,098	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
19.67	₹20 Cr	—	-0.4	0.12	-₹28 L

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr
-₹25 Cr	-₹24 Cr	-₹22 Cr	-₹21 Cr	-₹17 Cr	-₹12 Cr	-₹10 Cr	-₹8 Cr	-₹5 Cr	-₹5 Cr	-₹5 Cr	-₹4 Cr	-₹2 Cr	-₹2 Cr
-₹25 Cr	-₹24 Cr	-₹22 Cr	-₹21 Cr	-₹17 Cr	-₹12 Cr	-₹10 Cr	-₹8 Cr	-₹5 Cr	-₹5 Cr	-₹5 Cr	-₹4 Cr	-₹2 Cr	-₹2 Cr
-₹15 Cr	-₹14 Cr	-₹12 Cr	-₹11 Cr	-₹7 Cr	-₹2 Cr	₹37 L	₹2 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹8 Cr	₹8 Cr
₹0	₹6 L	₹26 L	₹44 L	₹57 L	₹0	₹0	₹2 L	₹8 L	₹0	₹0	₹0	₹0	₹22 L
₹19 Cr	₹19 Cr	₹18 Cr	₹18 Cr	₹15 Cr	₹15 Cr	₹11 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹2 Cr
-₹90 L	-₹96 L	-₹1 Cr	-₹2 Cr	-₹3 Cr	-₹4 Cr	-₹3 Cr	-₹2 Cr	-₹2 Cr	-₹1 Cr	-₹1 Cr	-₹2 Cr	-₹1 Cr	-₹1 Cr
₹18 Cr	₹18 Cr	₹17 Cr	₹16 Cr	₹13 Cr	₹11 Cr	₹8 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹1 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹3 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹6 Cr	₹6 Cr	₹3 Cr
₹2 Cr	₹2 Cr	₹55 L	₹32 L	₹2 Cr	₹59 L	₹60 L	₹2 Cr	₹2 Cr	₹2 Cr	₹98 L	₹1 Cr	₹97 L	₹58 L
₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹2 L	₹67 L	₹19 L	₹18 L	₹3 Cr
₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹98 L	₹67 L	₹66 L	₹93 L	₹70 L	₹38 L	₹33 L
₹10 Cr	₹9 Cr	₹8 Cr	₹7 Cr	₹12 Cr	₹8 Cr	₹9 Cr	₹11 Cr	₹10 Cr	₹5 Cr	₹5 Cr	₹8 Cr	₹8 Cr	₹7 Cr
₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹17 Cr	₹17 Cr	₹18 Cr	₹18 Cr	₹20 Cr	₹17 Cr	₹17 Cr	₹19 Cr	₹22 Cr	₹16 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹0	₹0	₹0	₹0	₹50 L	₹61 L	₹62 L	₹0	₹0	₹0
₹22 Cr	₹22 Cr	₹21 Cr	₹21 Cr	₹18 Cr	₹18 Cr	₹14 Cr	₹11 Cr	₹11 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹5 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹28 Cr	₹27 Cr	₹28 Cr	₹26 Cr	₹25 Cr	₹24 Cr	₹22 Cr	₹21 Cr
₹22 Cr	₹22 Cr	₹21 Cr	₹21 Cr	₹20 Cr	₹20 Cr	₹19 Cr	₹18 Cr	₹18 Cr	₹17 Cr	₹17 Cr	₹15 Cr	₹14 Cr	₹13 Cr
₹5 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹8 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹10 L	₹57 L	₹34 L
₹94,522	₹94,216	₹93,926	₹93,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520
₹94,522	₹94,216	₹93,926	₹93,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520	₹88,520
₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
₹7 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹11 Cr	₹11 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹6 Cr	₹2 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹3 Cr
₹4 L	₹4 L	₹2 L	₹2 L	₹2 L	₹6 L	₹8 L	₹10 L	₹5 L	-₹11 L	₹20 L	₹31 L	₹59 L	₹60 L
₹2 L	₹0	₹4 L	₹4 L	₹2 L	₹2 L	₹3 L	₹65,125	₹1 L	₹2 L	₹3 L	₹3 L	₹74,132	₹80,187
₹74 L	₹71 L	₹56 L	₹70 L	₹1 Cr	₹59 L	₹52 L	₹58 L	₹58 L	₹68 L	₹49 L	₹39 L	₹39 L	₹18 L
₹6 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹8 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹12 Cr	₹6 Cr
-₹4 Cr	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹60 L	-₹1 Cr	-₹3 Cr	-₹86 L	₹2 Cr	₹2 Cr	₹1 Cr	₹4 Cr	-₹58 L
₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹17 Cr	₹17 Cr	₹18 Cr	₹18 Cr	₹20 Cr	₹17 Cr	₹17 Cr	₹19 Cr	₹22 Cr	₹16 Cr
-₹15	-₹14	-₹13	-₹11	-₹7	-₹2	₹0	₹2	₹5	₹5	₹5	₹6	₹8	₹8
-₹15	-₹14	-₹13	-₹11	-₹7	-₹2	₹0	₹2	₹5	₹5	₹5	₹6	₹8	₹8

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
-₹1 Cr	-₹1 Cr	-₹1 Cr	-₹2 Cr	-₹4 Cr	-₹4 Cr	-₹2 Cr	-₹3 Cr	-₹1 Cr	₹4 L	-₹1 Cr	-₹1 Cr	-₹9 L	₹60 L
₹96 L	₹95 L	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹3 Cr	₹40 L	₹1 Cr	₹1 Cr
₹73 L	₹32 L	₹27 L	-₹95 L	₹3 Cr	-₹79 L	-₹1 Cr	₹3 Cr	-₹97 L	₹26 L	-₹1 Cr	₹2 Cr	-₹2 Cr	₹86 L
₹51 L	₹17 L	₹1 Cr	-₹1 Cr	₹1 Cr	-₹3 Cr	-₹2 Cr	₹80 L	-₹96 L	₹1 Cr	₹67 L	₹1 Cr	-₹56 L	₹2 Cr
₹51 L	₹17 L	₹1 Cr	-₹1 Cr	₹1 Cr	-₹3 Cr	-₹2 Cr	₹80 L	-₹96 L	₹1 Cr	₹67 L	₹1 Cr	-₹56 L	₹34 L
-₹39,425	₹5 L	-₹2 L	-₹9 L	-₹6 L	₹49,508	-₹29 L	-₹8 L	-₹2 Cr	-₹34 L	-₹88 L	-₹2 Cr	-₹1 Cr	-₹1 Cr
-₹50 L	-₹20 L	-₹1 Cr	₹1 Cr	-₹1 Cr	₹3 Cr	₹2 Cr	-₹66 L	₹3 Cr	-₹1 Cr	₹10 L	₹2 L	₹2 Cr	₹4 L
₹22,045	₹2 L	₹16,981	-₹20,874	-₹4 L	-₹2 L	-₹2 L	₹6 L	₹15 L	-₹31 L	-₹11 L	-₹28 L	-₹98,347	-₹62 L
₹4 L	₹2 L	₹2 L	₹2 L	₹6 L	₹8 L	₹10 L	₹5 L	-₹11 L	₹20 L	₹31 L	₹59 L	₹60 L	₹1 Cr
₹4 L	₹4 L	₹2 L	₹2 L	₹2 L	₹6 L	₹8 L	₹10 L	₹5 L	-₹11 L	₹20 L	₹31 L	₹59 L	₹60 L

Fundamental Ratios

Consolidated

Standalone

Norris Medicines Share Price

19.67+0.00 (+0.00%)

+18.21% past 1 Year

Shareholding summary

Promoters

34.01%

FII

DII

0.06%

0.01%

Others

65.92%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
34.01%	34.01%	34.00%	34.00%	34.00%	34.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.06%	0.06%	0.06%	0.06%	0.06%	0.06%
0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
65.92%	65.92%	65.93%	65.93%	65.93%	65.93%

Bulk & block deals

Name

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange

Insider trading & SAST

Client name

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type

Norris Medicines Share Price

19.67+0.00 (+0.00%)

+18.21% past 1 Year

Norris Medicines Ltd. is one of the leading Indian manufacturers of Injections and Medicinal formulations.

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

Plot No. 801 / P G I D C Industrial Estate Ankleshwar Gujarat PIN: 393002 Tel No: 02646 - 223462, 227530 Fax No: 02646 - 250126 Email: [email protected] Internet: www.norrispharma.com

Registrars

Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg Gala No 9 Shiv Shakti, Industrial Estate,Sitaram Mill Comp. J R Boricha Marg, Lower Parel [E] PIN: Tel No: +91 22 4134 3255/ +91 22 4134 3256 Fax No: NULL Email: [email protected] Internet: www.purvashare.com

Management

Vimal Shah, Executive Director

A Vadivel, Non Executive Independent Director

Praveen Bafna, Non Executive Director

Priyanka Lohiya, Company Secretary

Vimal Dhirendra Shah, Managing Director

Details

BSE 524414

NSE NULL

ISIN INE744C01029

Norris Medicines Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Norris Medicines Share Price

Norris Medicines Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Norris Medicines Share Price

Norris Medicines Share Price

Oscillators

Moving averages

Norris Medicines Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Norris Medicines Share Price

Corporate Actions

Company details

Norris Medicines Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Norris Medicines Share Price

News

Norris Medicines reports Profit after tax of 5.10 Lakhs, in the March 2026 quarter

Norris Medicines informs about compliances-certificate

Norris Medicines reports Profit after tax of 69.80 Lakhs, in the December 2025 quarter

Norris Medicines reports Profit after tax of Rs -71.80 Lakhs, in the September 2025 quarter

Norris Medicines reports Profit after tax of Rs -31.20 Lakhs, in the June 2025 quarter

Norris Medicines - Quaterly Results

Norris Medicines reports Profit after tax of Rs -22.90 Lakhs, in the March 2025 quarter

Norris Medicines - Quaterly Results

Norris Medicines informs about outcome of board meeting

Norris Medicines reports Profit after tax of Rs -28.20 Lakhs, in the December 2024 quarter

Norris Medicines - Quaterly Results

Norris Medicines reports Profit after tax of Rs -36.20 Lakhs, in the September 2024 quarter

Norris Medicines informs about newspaper publication

Norris Medicines reports Profit after tax of Rs -36.60 Lakhs, in the June 2024 quarter

Norris Medicines - Quaterly Results

Norris Medicines informs about change in management

Norris Medicines reports Profit after tax of 17.40 Lakhs, in the March 2024 quarter

Norris Medicines informs about outcome of directors meeting

Norris Medicines - Quaterly Results

Norris Medicines - Quaterly Results

Norris Medicines Ltd Share Price Today

Norris Medicines Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator